These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1893377)
1. Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study Group. Patel R; Newman EM; Villacorte DG; Sato JK; Reaman GH; Finklestein JZ; Krailo MD; Hammond GD; Holcenberg JS Cancer Res; 1991 Sep; 51(18):4871-5. PubMed ID: 1893377 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer. Newman EM; Akman SA; Harrison JS; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Somlo G; Ahn CW; Doroshow JH Cancer Res; 1992 May; 52(9):2408-12. PubMed ID: 1568210 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of diastereoisomers of (6R,S)-folinic acid (leucovorin) in humans during constant high-dose intravenous infusion. Newman EM; Straw JA; Doroshow JH Cancer Res; 1989 Oct; 49(20):5755-60. PubMed ID: 2676149 [TBL] [Abstract][Full Text] [Related]
4. A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors. Cassidy J; Dirix L; Bissett D; Reigner B; Griffin T; Allman D; Osterwalder B; Van Oosterom AT Clin Cancer Res; 1998 Nov; 4(11):2755-61. PubMed ID: 9829739 [TBL] [Abstract][Full Text] [Related]
5. A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions. Bailey H; Wilding G; Tutsch KD; Arzoomanian RZ; Alberti D; Tombes MB; Grem JL; Spriggs DR Cancer Chemother Pharmacol; 1992; 30(4):297-302. PubMed ID: 1643698 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin. Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874 [TBL] [Abstract][Full Text] [Related]
7. Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer. Mani S; Rudin CM; Kunkel K; Holmlund JT; Geary RS; Kindler HL; Dorr FA; Ratain MJ Clin Cancer Res; 2002 Apr; 8(4):1042-8. PubMed ID: 11948111 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration. Schilsky RL; Ratain MJ J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292 [TBL] [Abstract][Full Text] [Related]
9. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors. Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572 [TBL] [Abstract][Full Text] [Related]
10. Phase I trial of dipyridamole with 5-fluorouracil and folinic acid. Budd GT; Jayaraj A; Grabowski D; Adelstein D; Bauer L; Boyett J; Bukowski R; Murthy S; Weick J Cancer Res; 1990 Nov; 50(22):7206-11. PubMed ID: 2224854 [TBL] [Abstract][Full Text] [Related]
11. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant. Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043 [TBL] [Abstract][Full Text] [Related]
12. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study. Adamson PC; Widemann BC; Reaman GH; Seibel NL; Murphy RF; Gillespie AF; Balis FM Clin Cancer Res; 2001 Oct; 7(10):3034-9. PubMed ID: 11595692 [TBL] [Abstract][Full Text] [Related]
13. A phase II trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase I trial of intraperitoneal 5-fluorouracil and leucovorin. Arbuck SG; Douglass HO; Trave F; Rustum YM NCI Monogr; 1987; (5):203-5. PubMed ID: 3501544 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors. Pratt CB; Meyer WH; Howlett N; Douglass EC; Bowman LC; Poe D; Mounce K; Kun LE; Houghton JA Cancer; 1994 Nov; 74(9):2593-8. PubMed ID: 7923016 [TBL] [Abstract][Full Text] [Related]
15. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts. Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of high-dose zidovudine administered as a continuous infusion in patients with cancer. Marchbanks K; Dudley MN; Posner MR; Darnowski J Pharmacotherapy; 1995; 15(4):451-7. PubMed ID: 7479197 [TBL] [Abstract][Full Text] [Related]
17. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine. Marshall JL; Richmond E; DeLap RJ Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323 [TBL] [Abstract][Full Text] [Related]
18. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations. Bertrand R; Jolivet J J Natl Cancer Inst; 1989 Aug; 81(15):1175-8. PubMed ID: 2787408 [TBL] [Abstract][Full Text] [Related]
19. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers. Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775 [TBL] [Abstract][Full Text] [Related]
20. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer. Tan CT; Hancock CH; Mondora A; Hoffman NW Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]